Blood· 2022Q1· Review

Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN

Hartmut Döhner, Andrew H. Wei, Frederick R. Appelbaum, Charles Craddock et al.

3,068citations
Q1SCImago
2022year

Short summary

The European LeukemiaNet (ELN) has updated its 2022 recommendations for diagnosing and managing adult acute myeloid leukemia (AML), incorporating recent advances in molecular pathogenesis, genomic diagnostics, and novel therapies.

AI-generated from the title and abstract; the full text is not read.

TakeawaysIn the app

Key pointsIn the app

Ask the paperIn the app

The rest is in the Pofolia app

Takeaways, key points and questions to the paper; new summaries every day for your field. Free.

Get it on Google Play Download on the App Store

Field: Hematology

HematologyMedicine